Indaco Venture Partners

Navigare Ventures is an early-stage investor specialized in science-driven companies. Through our investments, we strengthen the industrial and societal impact of research, as well as the long-term financial capacity of our owners, Wallenberg Investments AB. Our core investment themes within deep tech are underpinned by our knowledge and network in a number of scientific fields and industries. These include advanced computing and quantum technologies, synthetic biology and bio innovation, advanced materials and nano technology as well as data-driven life science. We are long term investors - Seed and Series A and beyond - and form deep and lasting partnerships with founders and entrepreneurs. Our extensive industrial and scientific networks gives us the opportunity to provide capital, network, and know-how to transform promising science start-ups into successful companies. Who we are Navigare Ventures, based in Stockholm, is a fully owned subsidiary of Wallenberg Investments AB. We are a team of scientists, industrialists and entrepreneurs who understand the challenges of turning cutting-edge technologies to successful ventures. As part of the Wallenberg ecosystem, our returns fuel the next generation of scientific advancement through research funding from the Wallenberg Foundations to Swedish universities. What we are looking for We partner with experienced entrepreneurial teams that combine scientific excellence with strong business acumen. In this respect, your company should have a unique offering based on a profound understanding of your scientific or technological field and its market and industrial environment. You should also be capable of demonstrating the viability and commercial potential of your product by engaging with real customers. You are raising capital to scale the R&D, production, marketing, and sales capabilities of your company. Our investment philosophy We only invest in companies we understand. While this is an important general principle in any investment activity, it is even more important when making early-stage investments in new technology. If we don’t understand your science, we won’t understand what experts tell us about the value chain and how it works, or what the competitive landscape looks like. And most importantly, we won’t be able to help you develop your strategy and navigate through the challenges of deep-tech start-ups. So, when preparing a meeting with us, don’t put too much emphasis on future revenue projections. That’s important too, in due time. But first, be prepared for long sessions in front of a whiteboard, explaining to us how your material, algorithm, or antibody functions. We don’t need to understand all the equations, but we need to get the heuristics. We are scientists at heart, eager to learn, and we carry a deep conviction that the world is fundamentally understandable. Core investment themesAdvanced computing and quantum technologies: Digitization and automation deepens in industry and society, driven by breakthroughs in computing and AI. Our focus includes improving existing technologies as well as finding completely new platforms in AI and other areas of applied mathematics as well as in novel computer architectures, communication technology, hardware and design. Synthetic biology and bio innovation: Synthetic biology and bio innovations contribute to a more sustainable society. Companies in this field often combine principles of biology, engineering, and computer science for the development of new biological products and manufacturing methods. Advanced materials and nano technology: New materials and nanoscale technology enable disruptions with the potential to benefit numerous existing industries. From quantum materials to biomaterials and biologically inspired nanostructures, we look for the most promising technology platforms in the field. Data-driven life science: Combining digital technology and data with life science drives scientific understanding and enables novel products. Our focus is on data-driven methods to increase personalization and precision of medical interventions, accelerate product development, digitalize care among other advancements.

라플라스파트너스는 초기 단계 기술 기업들의 성장을 돕는 것을 소명으로 여기며, 시장을 확장하는 등 강한 목적의식을 가진 스타트업들과 협력하고 싶습니다. 비전 어떤 문제를 해결하고 세상에 어떤 변화를 가져오고 싶은지, 즉, 미래에 대한 명확한 비전을 그릴 수 있는 팀을 기대합니다. 이유 세상의 많은 문제들 중 왜 ‘그 문제’를 해결하고 싶은지에 대해 납득할 만한 이유가 있는 팀을 선호합니다 가치 ‘비전’과 ‘이유’를 바탕으로 고객에게 얼마나 유의미한 가치를 제공할 수 있는가에 집중합니다. 혁신 기술 라플라스파트너스는 혁신 기술로 문제를 해결하고 새로운 패러다임을 만들어가는 영역에 투자합니다. 바이오·헬스케어 제약, 혁신 진단 기기, 디지털 헬스케어, 건강 기능 식품, 푸드테크 등 소재·부품·장비 2차 전지, 반도체 소재·장비, 에너지, 신소재, 디스플레이, 통신 등 IT 인공지능(AI)의 응용, 전기차, 자율주행, 로봇, 메타버스, 증강현실(AR) 등

Cybernetix Ventures is a venture capital firm leading the way for investment into early-stage robotics, automation, and AI startups. Headquartered in Boston, the world’s epicenter for robotics innovation, Cybernetix connects its portfolio to the national and global robotics ecosystems, bringing unparalleled expertise to companies poised to make major impacts in sectors including advanced manufacturing, logistics/warehousing, architecture, engineering and construction and healthcare/medical devices. The fund will also invest in key robotics-enabling software companies in AI/machine learning, cloud robotics, cybersecurity, autonomy, and sensors/edge computing.

LiquidMetal Ventures is a newly established venture capital fund based in Boston, aiming at investing in early-stage (Seed, Angel, and pre-A round) in a minority group, particularly deep-tech startups. LiquidMetal Ventures is based on deep-tech start-up communities and has a unique advantage in reaching out to ‘off-the-market’ early-stage deals and cooperating with peer VC funds tightly to reduce the risk, overall a high return could be expected. LiquidMetal Ventures focuses on biotech and healthcare, carbon neutrality, AI and data, infrastructure, and consumer tech. There is a huge tide of startups among Boston entrepreneurs in the US on the way. We would like to be the first to check VC with the founders. Investment FocusBioTech Medical Device Sustainability AI & Data Science Advanced Energy Technology Robotics & Advanced Manufacturing

Our portfolio boasts over 300 active patents covering world-changing innovations. We back the teams we believe are best able to deploy revolutionary technologies. We have board representation at over 80% of our portfolio companies. We're committed to working alongside our founders to commercialize scientific discovery. Our portfolio companies have collectively raised over two billion dollars. We invest across the life cycle of a company from pre-seed to pre-IPO. Our Name The name, Fine Structure Ventures®, is perhaps most meaningful to the scientist-entrepreneurs we partner with. In physics, the fine-structure constant, commonly denoted by α (the Greek letter alpha), is named for the spacing between the spectral lines in the fine structure of the hydrogen atom. It is a dimensionless, fundamental physical constant which describes the interaction between elementary charged particles, such as electrons, and an electromagnetic field. If the value of alpha were much different from the one we know, it would impact whether nuclear fusion within stars produces carbon or whether atoms can form stable molecules–both of which are critical for life. The fine structure constant is moreover the single best predicted constant in all of physics. Quantum electrodynamics, a field founded by Julian Schwinger, Richard Feynman, and Freeman Dyson, predict its value from first principles, and the associated experiments match to 11 digits. At Fine Structure Ventures, we are also making predictions to realize alpha, used in this context to represent excess return on investment. We take a first principles approach, looking for technologies that, if realized at scale, would have obvious, dramatic, global impact. While we only aspire to the brilliance of Dyson or Feynman, we nevertheless seek unprecedented accuracy in our evaluation of investment opportunities. A Rich Legacy Fine Structure Ventures is rooted in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion under management. For the last fifty years, our independent venture capital group has had the privilege of backing other great entrepreneurs as they built ground-breaking companies, including Atari and MCI in the early days. A Focused Team of Specialists Although we are backed by a resourceful global platform, we are a small team passionate about the impact science can make and singularly focused on the success of the entrepreneurs we are privileged to work with. We bring together decades of experience in investments, operations, entrepreneurship, and in scientific research.